Table 3 Associations between medications and perioperative infectious complications of cervical spine surgery in patients with RA (n=12)

Biologics/JAK inhibitor, n (%)

18

2 (11.1)

.688

1 (5.56)

.789

w/o Biologics/JAK inhibitor, n (%)

121

10 (8.26)

5 (4.41)

Methotrexate, n (%)

57

4 (7.02)

.572

2 (3.51)

.693

w/o Methotrexate, n (%)

82

8 (9.76)

4 (4.89)

Prednisolone, n (%)

118

10 (8.47)

.875

6 (5.1)

.156

w/o Prednisolone, n (%)

21

2 (9.52)

0 (0)